Kailera Therapeutics, Inc. (KLRA): 8-K filed Apr 20, 2026

Form type

8-K

Filing date

Apr 20, 2026

Accession number

0001193125-26-164040

Filer

Kailera Therapeutics, Inc. (CIK 2096997)